Zobrazeno 1 - 10
of 10
pro vyhledávání: '"E Aniwada"'
Perception, acceptability and challenges of digital adherence technology among TB healthcare workers
Autor:
I. Gordon, B. Odume, C. Ogbudebe, O. Chukwuogo, N. Nwokoye, S. Useni, E. Efo, M. Gidado, E. Aniwada, A. Ihesie, D. Nongo, R. Eneogu, O. Chijioke-Akaniro, C. Anyaike
Publikováno v:
Public Health Action, Vol 14, Iss 2, Pp 61-65 (2024)
INTRODUCTION: Successful treatment of TB requires high levels of adherence to treatment. This has been found to be below optimal with directly observed therapy (DOT), and digital adherence technologies (DATs) offer a promising approach to non-adheren
Externí odkaz:
https://doaj.org/article/9349ab50b44b4d09a15224c221acf14d
Autor:
C. Ogbudebe, B. Odume, I. Gordon, O. Chukwuogo, N. Nwokoye, S. Useni, E. Efo, M. Gidado, E. Aniwada, A. Ihesie, D. Nongo, R. Eneogu, O. Chijioke-Akaniro, C. Anyaike
Publikováno v:
Public Health Action, Vol 14, Iss 2, Pp 66-70 (2024)
INTRODUCTION: Poor adherence to TB treatment poses a significant public health threat to TB control programmes. The sustainability of directly observed treatment has been questioned because of its non-patient-centred approach and resource-intensive n
Externí odkaz:
https://doaj.org/article/4978b7de00234763a6e93b93f8c17fef
Publikováno v:
Journal of Advances in Medicine and Medical Research. 27:1-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gordon I; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Odume B; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Ogbudebe C; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Chukwuogo O; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Nwokoye N; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Useni S; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Efo E; KNCV TB Plus, The Hague, Netherlands., Gidado M; KNCV TB Plus, The Hague, Netherlands., Aniwada E; Department of Community Medicine, University of Nigeria Teaching Hospital, Enugu., Ihesie A; United States Agency for International Development (USAID), Abuja., Nongo D; United States Agency for International Development (USAID), Abuja., Eneogu R; United States Agency for International Development (USAID), Abuja., Chijioke-Akaniro O; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria., Anyaike C; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2024 Jun 01; Vol. 14 (2), pp. 61-65. Date of Electronic Publication: 2024 Jun 01 (Print Publication: 2024).
Autor:
Ogbudebe C; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Odume B; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Gordon I; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Chukwuogo O; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Nwokoye N; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Useni S; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Efo E; KNCV TB Plus, The Hague Netherlands., Gidado M; KNCV TB Plus, The Hague Netherlands., Aniwada E; Department of Community Medicine, University of Nigeria Teaching Hospital, Enugu., Ihesie A; United States Agency for International Development (USAID), Abuja, Nigeria., Nongo D; United States Agency for International Development (USAID), Abuja, Nigeria., Eneogu R; United States Agency for International Development (USAID), Abuja, Nigeria., Chijioke-Akaniro O; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria., Anyaike C; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2024 Jun 01; Vol. 14 (2), pp. 66-70. Date of Electronic Publication: 2024 Jun 01 (Print Publication: 2024).
Autor:
Odume B; Technical Division, KNCV Tuberculosis Nigeria, Abuja., Falokun V; Technical Division, KNCV Tuberculosis Nigeria, Abuja., Chukwuogo O; Technical Division, KNCV Tuberculosis Nigeria, Abuja., Ogbudebe C; Technical Division, KNCV Tuberculosis Nigeria, Abuja., Useni S; Technical Division, KNCV Tuberculosis Nigeria, Abuja., Nwokoye N; Technical Division, KNCV Tuberculosis Nigeria, Abuja., Aniwada E; Public Health, University of Nigeria Teaching Hospital, Enugu., Olusola Faleye B; SHOPS (Strengthening Health Outcomes through the Private Sector) Plus Project, Abt Associates, Abuja., Okekearu I; SHOPS (Strengthening Health Outcomes through the Private Sector) Plus Project, Abt Associates, Abuja., Nongo D; TB/HIV Unit USAID, Abuja., Odusote T; TB/HIV Unit USAID, Abuja., Lawanson A; National Tuberculosis and Leprosy Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2020 Dec 21; Vol. 10 (4), pp. 157-162.